March 3, 2025 · Form 4 insider transaction
Barnes Wendy Lynn bought 2,828,232 shares of GoodRx Holdings, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The option will vest and become exercisable as to 25% of the underlying shares on January 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to early exercise and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting.